Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

6.00

+0.07 (1.18%)

At close: Sep 4, 2026, 4:00 PM EDT

6.01

+0.01 (0.15%)

After-hours: Sep 4, 2026, 7:30 PM EDT

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56.23	78.44	23.36	14.47	14.22	32.94
Short-Term Investments	90.6	112.97	74.36	37.75	37.93	12.09
Cash & Short-Term Investments	146.83	191.4	97.72	52.23	52.15	45.02
Cash Growth	-34.89%	95.87%	87.11%	0.15%	15.82%	-52.62%
Accounts Receivable	9.39	6.15	-	-	-	3
Other Receivables	0.5	0.57	1.65	2.44	0.19	-
Receivables	9.89	6.72	1.65	2.44	0.19	3
Inventory	5.92	5.49	-	-	-	-
Prepaid Expenses	1.94	1.29	1.14	0.73	0.42	2.38
Restricted Cash	-	-	0.34	0.34	0.34	5.89
Total Current Assets	164.58	204.91	100.85	55.74	53.1	56.29
Property, Plant & Equipment	14.1	13.88	7.98	7.99	11.07	21.74
Other Intangible Assets	-	-	-	-	-	1.38
Other Long-Term Assets	0.83	0.78	0.1	0.28	0.04	0.17
Total Assets	179.51	219.57	108.93	64	64.21	79.59

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.99	7.89	3.44	1.86	1.81	4.33
Accrued Expenses	7.2	8.47	6.33	5.99	3.99	5.59
Current Portion of Long-Term Debt	13.33	12.22	5.93	-	-	-
Current Portion of Leases	1.28	0.86	0.82	1	1.77	1.82
Current Income Taxes Payable	0	0.13	-	-	-	-
Other Current Liabilities	-	0	0.06	4.58	0.2	4.9
Total Current Liabilities	24.81	29.57	16.59	13.42	7.78	16.62
Long-Term Debt	1.66	7.81	13.04	-	-	-
Long-Term Leases	3.6	4.07	3.26	4.4	5.85	7.56
Long-Term Unearned Revenue	0.68	-	-	-	-	-
Other Long-Term Liabilities	20.71	18.9	32.01	31.35	23.82	13.04
Total Liabilities	51.45	60.35	64.9	49.18	37.45	37.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.57	0.55	0.46	0.27	0.18	1.47
Additional Paid-In Capital	906.91	900.6	856.82	764.15	722.05	696.56
Retained Earnings	-779.34	-742.08	-813.26	-749.52	-695.34	-655.64
Comprehensive Income & Other	-0.08	0.14	0.01	-0.07	-0.13	-0.03
Shareholders' Equity	128.06	159.22	44.03	14.83	26.76	42.37
Total Liabilities & Equity	179.51	219.57	108.93	64	64.21	79.59

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	19.87	24.97	23.05	5.4	7.63	9.38
Net Cash (Debt)	126.95	166.44	74.67	46.83	44.52	35.65
Net Cash Growth	-36.98%	122.89%	59.47%	5.17%	24.90%	-58.70%
Net Cash Per Share	2.28	2.52	1.82	2.19	5.66	9.05
Filing Date Shares Outstanding	57.18	57.05	48.53	27.36	17.71	5.9
Total Common Shares Outstanding	57.23	55.04	45.64	26.52	17.72	5.89
Working Capital	139.77	175.34	84.27	42.32	45.32	39.67
Book Value Per Share	2.24	2.89	0.96	0.56	1.51	7.20
Tangible Book Value	128.06	159.22	44.03	14.83	26.76	40.98
Tangible Book Value Per Share	2.24	2.89	0.96	0.56	1.51	6.96
Machinery	13.18	12.02	9.98	7.92	9.02	10.98
Construction In Progress	0.06	-	0.62	-	-	3.22
Leasehold Improvements	15.48	15.12	8.81	8.6	8.61	8.6

SEC Filings: 10-K · 10-Q